☰

Aditya S. Vaidya, Ph.D. - Publications

Affiliations: 
2013 Medicinal Chemistry and Pharmacognosy University of Illinois at Chicago, Chicago, IL, United States 
Area:
Biochemistry, Genetics, Cell Biology
Tree Info Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Vaidya AS, Helander JDM, Peterson FC, Elzinga D, Dejonghe W, Kaundal A, Park SY, Xing Z, Mega R, Takeuchi J, Khanderahoo B, Bishay S, Volkman BF, Todoroki Y, Okamoto M, et al. Dynamic control of plant water use using designed ABA receptor agonists. Science (New York, N.Y.). 366. PMID 31649167 DOI: 10.1126/Science.Aaw8848  0.313
2019 Elzinga D, Sternburg E, Sabbadin D, Bartsch M, Park SY, Vaidya A, Mosquna A, Kaundal A, Wendeborn S, Lachia M, Karginov FV, Cutler SR. Defining and Exploiting Hypersensitivity Hotspots to Facilitate Abscisic Acid Agonist Optimization. Acs Chemical Biology. PMID 30668093 DOI: 10.1021/Acschembio.8B00955  0.359
2017 Petukhov PA, Abdelkarim H, Neelarapu R, Madriaga A, Kastrati I, Wang YT, Vaidya AS, Taha TY, Thatcher GRJ, Frasor J. Design, Synthesis, Molecular Modeling, and Biological Evaluation of Novel Amine-based Histone Deacetylase Inhibitors. Chemmedchem. PMID 29080240 DOI: 10.1002/Cmdc.201700449  0.601
2017 Vaidya AS, Peterson FC, Yarmolinsky D, Merilo E, Verstraeten I, Park SY, Elzinga D, Kaundal A, Helander J, Lozano-Juste J, Otani M, Wu K, Jensen DR, Kollist H, Volkman BF, et al. A rationally designed agonist defines subfamily IIIA ABA receptors as critical targets for manipulating transpiration. Acs Chemical Biology. PMID 28949512 DOI: 10.1021/Acschembio.7B00650  0.334
2014 Patel HK, Siklos MI, Abdelkarim H, Mendonca EL, Vaidya A, Petukhov PA, Thatcher GR. A chimeric SERM-histone deacetylase inhibitor approach to breast cancer therapy. Chemmedchem. 9: 602-13. PMID 23956109 DOI: 10.1002/Cmdc.201300270  0.589
2014 Patel HK, Siklos MI, Abdelkarim H, Mendonca EL, Vaidya A, Petukhov PA, Thatcher GRJ. Cover Picture: A Chimeric SERM-Histone Deacetylase Inhibitor Approach to Breast Cancer Therapy (ChemMedChem 3/2014) Chemmedchem. 9: 413-413. DOI: 10.1002/Cmdc.201490005  0.581
2012 Vaidya AS, Neelarapu R, Madriaga A, Bai H, Mendonca E, Abdelkarim H, van Breemen RB, Blond SY, Petukhov PA. Novel histone deacetylase 8 ligands without a zinc chelating group: exploring an 'upside-down' binding pose. Bioorganic & Medicinal Chemistry Letters. 22: 6621-7. PMID 23010266 DOI: 10.1016/J.Bmcl.2012.08.104  0.566
2012 Vaidya AS, Karumudi B, Mendonca E, Madriaga A, Abdelkarim H, van Breemen RB, Petukhov PA. Design, synthesis, modeling, biological evaluation and photoaffinity labeling studies of novel series of photoreactive benzamide probes for histone deacetylase 2. Bioorganic & Medicinal Chemistry Letters. 22: 5025-30. PMID 22771007 DOI: 10.1016/J.Bmcl.2012.06.017  0.576
Show low-probability matches.